Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Carlos H.R. Boasquevisque"'
Autor:
G. Alexander Patterson, Ronald K. Scheule, Jon M. Ritter, Lihui Qin, Mariano Boglione, Jonathan S. Bromberg, Carlos H.R. Boasquevisque, Lisa A. DeBruyne, Nelson S. Yew, Bassem N. Mora
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 119:913-920
Background: The aim of the current work was to study the feasibility of functional gene transfer using the gene encoding for transforming growth factor–β1, a known immunosuppressive cytokine, on rat lung allograft function in the setting of acute
Autor:
G. Alexander Patterson, Carlos H.R. Boasquevisque, Itaru Nagahiro, Masafumi Hiratsuka, Joel D. Cooper, Tyler White, Motoki Yano
Publikováno v:
The Annals of Thoracic Surgery. 66:351-355
Recombinant Kunitz protease inhibitor (rKPI-BG022) is more homologous to human Kunitz protease inhibitor than is aprotinin. Because aprotinin has been reported to inhibit free radicals, we hypothesized that rKPI would ameliorate reperfusion injury ca
Autor:
G. Alexander Patterson, Ronald K. Scheule, Jennifer B. Nietupski, William O. Osburn, Carlos H.R. Boasquevisque, Joel D. Cooper, Matthew Bernstein, Bassem N. Mora, M D Botney
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 115:38-44
Objective: Gene therapy is a promising strategy to modify ischemia-reperfusion injury and rejection after transplantation. We evaluated variables that may affect ex vivo gene transfer to rat lung isografts. Methods: Left lungs were harvested and perf
Autor:
William O. Osburn, Wei Zhang, Bassem N. Mora, David Peterson, G. Alexander Patterson, Teng C. Lee, Joel D. Cooper, Ronald K. Scheule, Jennifer B. Nietupski, Carlos H.R. Boasquevisque, M D Botney, Matthew Bernstein
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 114(5):783-792
Objectives: Our objectives were to determine the feasibility, efficacy, and safety of in vivo and ex vivo liposome-mediated gene transfer to lung isografts. Methods: Fischer rats were divided into three main groups: (1) Nontransplant setting: Liposom
Autor:
G. Alexander Patterson, Ronald K. Scheule, Joel D. Cooper, Carlos H.R. Boasquevisque, M D Botney, Motoki Yano
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 114:793-802
Objective: Gene transfer to lung grafts may be useful in ameliorating ischemia-reperfusion injury and rejection. Efficient gene transfection to the whole organ may prove problematic. Proximal pulmonary artery endothelial transfection might provide be
Autor:
Itaru Nagahiro, G. Alexander Patterson, Ralph A. Schmid, Bassem N. Mora, Teng C. Lee, Joel D. Cooper, Carlos H.R. Boasquevisque
Publikováno v:
The Annals of Thoracic Surgery. 63:1556-1560
Background. Although whole-organ gene transfer has been reported in heart and liver transplant models, it has not been well characterized in lung grafts. The aim of this study was to determine the feasibility of ex vivo gene transfer to rat lung isog
Autor:
Itaru Nagahiro, G. Alexander Patterson, Carlos H.R. Boasquevisque, Shozo Fujino, Joel D. Cooper, Anastasios N. Triantafillou, Motoki Yano
Publikováno v:
The Annals of Thoracic Surgery. 63:1383-1389
Inhalation of nitric oxide (NO) has been shown to have beneficial effects on a variety of acute lung injuries, including lung allograft reperfusion injury. The purpose of the present study was to investigate the effects of inhaled NO at the time of h
Autor:
Michael J. Welch, Timothy J. McCarthy, Mariano Boglione, Bassem N. Mora, Geoffrey L. Uy, G. Alexander Patterson, Carlos H.R. Boasquevisque
Publikováno v:
The Annals of thoracic surgery. 69(1)
Increased nitric oxide production accompanies acute lung allograft rejection. Transforming growth factor-beta1 is an immunosuppressive cytokine capable of ameliorating acute rejection. The purpose of this study was to determine whether exhaled nitric
Autor:
Carlos H.R. Boasquevisque, Richard Lee, Joel D. Cooper, Mariano Boglione, Masafumi Hiratsuka, G. Alexander Patterson, Ronald K. Scheule
Publikováno v:
The Annals of thoracic surgery. 66(3)
Background. Gene therapy is a promising strategy for the treatment of inoperable pulmonary tumors and rejection after lung transplantation. However, unlike ex vivo administration, intravenous in vivo transfection lacks organ specificity and has a lim
Autor:
Carlos H.R. Boasquevisque, Alan L. Schwartz, Ralph A. Schmid, Ando K, Joel D. Cooper, Masaaki Narita, G.A. Patterson, Botney
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 11(6)
Objective: New methods to introduce genetic material into cells in vivo may revolutionize current treatment modalities. Expression of functional genes in lung allografts could be used as a prophylactic strategy for reperfusion injury and rejection. W